According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with about 8.2 million deaths in 2012 alone. This is expected to rise by 70 percent over the next 20 years. There are over 100 types of cancers, but lung, liver, stomach, colorectal, breast and oesophageal are the most common.
Scientists and health experts have been looking for the cure of cancer for ages, and there hasn’t been any clear result. Fortunately, a new study has found that a simple drug we have been using all along can help us with this deadly disease.
How aspirin can almost double your chance of surviving cancer is explained in this article by Sophie Borland on the Daily Mail:
Aspirin could almost double your chance of surviving cancer: Three quarter of bowel, stomach and throat patients taking a daily dose were still alive five years later
Aspirin almost doubles the survival chances of many cancer sufferers, a study reveals today.
It found that 75 per cent of patients taking a daily dose were still alive five years after being diagnosed with bowel, stomach, pancreatic and throat cancer.
But the survival rate for those not on aspirin was just 42 per cent. Experts say the drug is a ‘magic bullet’ that should now be prescribed as soon as cancer is diagnosed. Read more…
Cancer is more prominent in developing countries, so aspirin use as a possible way to survive cancer is indeed a good news, since it is way cheaper compared to other cancer drugs and treatment.
As a preventable disease, cancer can be avoided by switching to a healthy lifestyle. Always aim for a healthy diet, which means more fruits and vegetables instead of processed foods, exercise daily, and avoid alcohol and tobacco use. True, aspirin can almost double your chance of surviving cancer, but it’s still important to prevent it long before it starts.
Image Credit: Aspirin could almost double your chance of surviving cancer – Daily Mail
The post Study Shows Aspirin Can Almost Double Your Chance of Surviving Cancer appeared first on NUTRITIONCLUB.
No comments:
Post a Comment